Searched for
INSULIN SENSITISER
- DRL’s anti-diabetes drug to hit market by ’11Dr Reddy’s anti-diabetes molecule Balaglitazone, which has entered the final phase of clinical development, is expected to hit the world ma...16 Nov, 2007, 02.51 AM IST
- How Dr Reddy's chased diabetes molecule dreamDr Reddy’s pursuit of past 13 years for the type 2 diabetes molecule is in its last lap, with the product entering the final phase of clini...09 Aug, 2007, 05.45 AM IST
- Foreign players look at India to develop lower-cost drugsGerman pharma major Boehringer Ingelheim is close to completing its first in-licensing deal with an Indian pharmaceutical company.23 May, 2007, 12.18 AM IST
- Wanted, MNC alliesNew drug discoveries are the pharmaceutical equivalent of an alchemist’s search for a magic formula to turn base metals into gold.12 Sep, 2006, 01.55 AM IST
Load More- DRL’s anti-diabetes drug to hit market by ’11
